E-Prescription Market Size

SkyQuest Technology's E-prescription market size, share and forecast Report is based on the analysis of market data and Industry trends impacting the global E-Prescription Market and the revenue of top companies operating in it. Market Size Data and Statistics are based on the comprehensive research by our Team of Analysts and Industry experts.

E-Prescription Market Insights

Global E-Prescription Market size was valued at USD 3.66 billion in 2023 and is poised to grow from USD 4.64 billion in 2024 to USD 31.01 billion by 2032, growing at a CAGR of 26.8% during the forecast period (2025-2032).

Prescription mistakes account for more than 72% of drug errors reported by hospitals and general practice settings, they are the main source of worry for healthcare workers worldwide. Although these mistakes seldom result in death, they can seriously harm a patient’s health. Prescription errors not only put patients’ health at risk but also frequently result in lawsuits for medical and legal misconduct against doctors and other medical professionals.

Medical professionals and other doctors can send computer-based electronic production and transmission of a medical prescription to a hospital-based or freestanding pharmacy using the technology framework known as electronic prescribing, or e-prescribing. Through e-prescribing software, medical providers can safely send prescriptions to pharmacies. These systems have a number of added advantages, including increased patient safety and higher-quality healthcare by avoiding drug interactions and minimising prescription errors. For doctors and other medical professionals, it is more affordable and practical than traditional prescription filling methods, which take a lot of time. During the projection period, expanding use of these systems in various medical facilities will significantly increase demand for them.

US E-Prescription Market is poised to grow at a sustainable CAGR for the next forecast year.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global E-Prescription Market size was valued at USD 3.66 billion in 2023 and is poised to grow from USD 4.64 billion in 2024 to USD 31.01 billion by 2032, growing at a CAGR of 26.8% during the forecast period (2025-2032).

Global E-Prescription Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'CVS Health Corporation (United States) ', 'Giant Eagle Inc. (United States) ', 'Lloyds Pharmacy Limited (United Kingdom) ', 'Rowland Pharmacy (United Kingdom) ', 'The Kroger Co. (United States) ', 'Walmart Inc. (United States) ', 'Cerner Corporation (United States) ', 'Allscripts Healthcare Solutions, Inc. (United States) ', 'McKesson Corporation (United States) ', 'Athenahealth, Inc. (United States) ', 'Medtronic plc (Ireland) ', 'Siemens Healthineers AG (Germany) ', 'GE Healthcare (United States) ', 'Philips Healthcare (Netherlands) ', 'IBM Watson Health (United States) ', 'Oracle Corporation (United States)'

Medication errors can have adverse effects on a patient’s health Healthcare professionals can access patient medical histories, medication information, and diagnoses through the use of e-prescribing systems, improving patient safety by preventing or minimising medical errors. Therefore, the prevalence of medical errors and drug side effects will rise globally, which will accelerate the implementation of e-prescribing systems.

The market will grow greatly as a result of the e-prescribing software being integrated into EHR solutions. Clinical notes, laboratory data, and a wide spectrum of clinical decision assistance are just a few benefits of integrated EHRs that standalone systems do not have. E-prescription with connected EHRs improves patient medication histories and pharmacy benefits information availability, making potentially life-saving drug data instantly accessible. Prescription mistakes have been significantly decreased by EHR-based systems in community-based medical practises, which has increased product adoption and boosted market growth over the course of the projection period. Another important element boosting the market is the government’s growing initiatives to deploy integrated EHR across numerous hospitals.

North America dominated the market in 2021, owing to the healthcare industry’s growing digitalization, favourable government policies, and a flexible regulatory environment. Regional expansion will also be aided in the predicted period by rising private and public investment for the implementation of integrated EHRs. For instance, the Cooperative Agreement Notice of Funding Opportunity was published by the Office of the National Coordinator for Health Information Technology (ONC) (NOFO). This program’s goal is to make it possible for the technical standards required to achieve interoperability among healthcare IT systems to advance.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global E-Prescription Market
E-Prescription Market

Report ID: SQMIG35F2007

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE